Jillian B. Thomsen
NKTRJillian B. Thomsen serves as Chief Financial Officer at Nektar Therapeutics (NKTR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Jillian B. Thomsen's Insider Trading at Nektar Therapeutics (NKTR)
Buys
0 · $0.00
Sells
8 · $647.1K
Total Shares Bought
0
Total Shares Sold
65,043
Related Insiders
ROBIN HOWARD W
director, officer: President & CEO
NKTRSell · Feb 18, 2026
ROBIN HOWARD W
President & CEO
NKTRSell · Feb 18, 2026
Jonathan Zalevsky
Chief R&D Officer
NKTRSell · Feb 18, 2026
Jonathan Zalevsky
officer: Chief R&D Officer
NKTRSell · Feb 18, 2026
Mark Andrew Wilson
Chief Legal Officer
NKTRSell · Nov 25, 2025